Sort
46,585 grants matching “heart failure”
The Virtual Mentored Implementation to Reduce REVISITS (Reducing Respiratory Emergent Visits using Implementation Science Interventions Tailored to Setting) Study
$769,343Valerie G Press · University Of Chicago · R01 · FY2022 · HL
Personalized Risk Prediction to Reduce Cardiovascular Disease in Childhood Cancer Survivors
$769,340Rebecca Maureen Howell · University Of Tx Md Anderson Can Ctr · R01 · FY2024 · CA
RCT of automated hovering for congestive heart failure management
$769,315Kevin G Volpp · University Of Pennsylvania · R01 · FY2017 · HL
Novel cardiopulmonary exercise testing variables to differentiate neuromuscular deconditioning from disease
$769,307Harry B Rossiter · Lundquist Institute For Biomedical Innovation At Harbor-Ucla Medical Center · R01 · FY2024 · HL
Push-Button Cardiac MRI for Non-Invasive Quantification of Myocardial Energy Consumption in Heart Failure
$769,199Hsin-Jung Yang · Cedars-Sinai Medical Center · R01 · FY2024 · HL
Characterization and Genetics of KI toxicity in iPSC-derived cardiomyocytes
$769,173Ulrich Broeckel · Medical College Of Wisconsin · R01 · FY2018 · HL
Oct4 and Klf4 regulate microvascular SMC-pericyte plasticity, angiogenesis, and metabolic dysfunction
$769,034Gary K Owens · University Of Virginia · R01 · FY2020 · HL
Oct4 and Klf4 regulate microvascular SMC-pericyte plasticity, angiogenesis, and metabolic dysfunction
$769,034Gary K Owens · University Of Virginia · R01 · FY2019 · HL
Oct4 and Klf4 regulate microvascular SMC-pericyte plasticity, angiogenesis, and metabolic dysfunction
$769,034Gary K Owens · University Of Virginia · R01 · FY2018 · HL
Genomic Signatures for Idiopathic Interstitial Pneumonia
$769,004David Albert Schwartz · National Jewish Health · R01 · FY2009 · HL
Plasticity of nTS output neurons in acute and chronic hypoxia
$768,979David Douglas Kline · University Of Missouri-Columbia · R01 · FY2020 · HL
Molecular Mechanisms of Atrial Fibrillation: A Multimodal Analysis
$768,911Nipavan Chiamvimonvat · University Of California At Davis · R01 · FY2024 · HL
The emerging role of apelin, RAAS, and ACE2 crosstalk in pulmonary hypertension
$768,905Andrea Lee Frump · Indiana University Indianapolis · R01 · FY2024 · HL
Serum Vitamin D and Cardiovascular Disease Risk in the Biethnic ARIC Cohort
$768,891Pamela L. Lutsey · University Of Minnesota · R01 · FY2012 · HL
Eicosanoid Profiles as Determinants of HFpEF
$768,855Jennifer E Ho · Massachusetts General Hospital · R01 · FY2020 · HL
Eicosanoid Profiles as Determinants of HFpEF
$768,855Jennifer E Ho · Massachusetts General Hospital · R01 · FY2019 · HL
The impact of the Supplemental Nutrition Assistance Program on the cardiovascular health of low-income adults
$768,849Sameed Ahmed Mustafa Khatana · University Of Pennsylvania · R01 · FY2024 · HL
The Role of Vascular MR-Regulated Genes in Vascular Function and Disease
$768,831Iris Z Jaffe · Tufts Medical Center · R01 · FY2024 · HL
Cardioprotective Therapy for Doxorubicin Using iPSC Microtissue and CRISPR Screening
$768,819Joseph C Wu · Stanford University · R01 · FY2022 · HL
Classification and Prognostication in Pulmonary Thromboembolism Using Computed Tomography Image Analytics
$768,679Farbod Nicholas Rahaghi · Brigham And Women'S Hospital · R01 · FY2022 · HL
IL1beta signaling in SMCpromotes beneficial changes in late stage atherosclerotic lesion pathogenesis
$768,674Gary K Owens · University Of Virginia · R01 · FY2021 · HL
IL1beta signaling in SMCpromotes beneficial changes in late stage atherosclerotic lesion pathogenesis
$768,674Gary K Owens · University Of Virginia · R01 · FY2022 · HL
Development of Fibrin-Specific Nuclear Probe to Reduce LVAD Adverse Events
$768,622James Blackledge · Capella Imaging, Llc · R42 · FY2018 · HL
PET imaging of Chemotherapy-Induced Cardiotoxicity
$768,567Vijay Sharma · Washington University · R01 · FY2025 · HL
Development of a Multimodal Biomaker Platform for Predictive Risk Stratification of Cardiac Disease in Duchenne Muscular Dystrophy
$768,551Jonathan Harvey Soslow · Vanderbilt University Medical Center · R56 · FY2018 · HL